Aralez Pharma (ARLZ) Misses Q1 EPS by 48c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Aralez Reports First Quarter 2016 Financial Results
May 10, 2016 7:01 AM EDT-First Quarter 2016 Includes the Operations of Tribute from February 5, 2016 through March 31, 2016-
MILTON, Ontario, May 10, 2016 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company"), today announced financial results for the first quarter ended March 31, 2016. The Company also highlighted important corporate, commercial, and regulatory updates. All figures are in U.S. dollars.
Corporate Updates:
On April 25, 2016, the Company announced... More